Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.60 -3.54% 70.90 898,258 16:35:08
Bid Price Offer Price High Price Low Price Open Price
70.00 71.00 73.50 69.00 73.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.06 -20.38 -55.00 40
Last Trade Time Trade Type Trade Size Trade Price Currency
17:10:15 O 73 70.904 GBX

Genedrive (GDR) Latest News

More Genedrive News
Genedrive Investors    Genedrive Takeover Rumours

Genedrive (GDR) Discussions and Chat

Genedrive Forums and Chat

Date Time Title Posts
11/5/202108:13Genedrive. A Game Changer for Global Covid 19 Testing Market?6,271
23/4/202116:12is share price move coming soon28
23/4/202108:05Genedrive (GDR) One to Watch 945
01/4/202114:17The New Genedrive Thread31
12/2/202108:34Genedrive PLC (GDR) Covid19 Diagnostics930

Add a New Thread

Genedrive (GDR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-05-11 16:10:1770.907351.76O
2021-05-11 16:06:5070.9034,94624,776.71O
2021-05-11 15:35:0870.902,2531,597.38UT
2021-05-11 15:26:4470.17711498.87O
2021-05-11 15:26:3270.002014.00O
View all Genedrive trades in real-time

Genedrive (GDR) Top Chat Posts

DateSubject
11/5/2021
09:20
Genedrive Daily Update: Genedrive Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 73.50p.
Genedrive Plc has a 4 week average price of 65.50p and a 12 week average price of 61p.
The 1 year high share price is 215p while the 1 year low share price is currently 38.50p.
There are currently 56,474,463 shares in issue and the average daily traded volume is 1,187,492 shares. The market capitalisation of Genedrive Plc is £40,040,394.27.
10/5/2021
12:57
cork4: Buying share pressing share price up more .
30/4/2021
11:34
cork4: Big sells look to be holding share price back. 50k 27k. 16k -
23/4/2021
10:00
petersinthemarket: Happily, the filter button works really well, but it doesn't leave much of any sense to read on here. And I still can't see when, or even if, this investment is going to pay off. share price still slopping around at about 50% of it's previous best price and most investors on here probably still under water.
22/4/2021
00:02
cork4: ABbynat.yea when one reads RNS so much news due. with the interest and buying seen Today . interesting days and weeks ahead and a rerate with share price if the interest and number of buys seen Today are seen
21/4/2021
11:40
cork4: Like this share .looks so undervalued.pleased to have been able to buy at so low a share price with so much news due .like that a major such as B C selling these tests. Roll on more news.
09/3/2021
09:06
gordan ghetto: ANA is the best UK cannabis stock Share price 1.1p Only £6.4m mkt cap Fastest growing sector worldwide Will have first mover advantage in UK Same growers as GW Pharma 4 biggest shareholders hold over 50% BOD own 30% Massively undervalued (£6.4m mkt cap) Near term multi bagger on license approval Partners with leading prof , scientists etc Primed for a RTO/ main listing (price driver) Under the radar (most chased MXC,CBX) Looking to bring a product to market Off take agreement in place already Will be producing 200 TONS per year (200,000 kilos) Has the most land out of every cannabis co Fully funded for phase 1 UK medical cannabis growing 20% month Only 584m shares in issue Hardly any available in open market Will apply for a commercial license too Worth getting in on the ground floor imho. hTTps://businesscann.com/work-on-12m-medicinal-cannabis-cultivation-facility-held-up-by-covid-19-uk-travel-ban/ hTTps://anandadevelopments.com/tiamat-agriculture-ltd/
25/2/2021
19:41
neo26: Rayj cracks me up..Nothing is certain, nyct and odx got into it early on in the pandemic.Gdr has just got in and hav a partner. The beads are not fda approved but can be used.It will take some months before any meaningful sale numbers come in.It may go down further we cannot predict but what i do know is that within 6 months this will be alot higher than current share price A few ii's are selling hence the price not moving upwards...With this stick put your money in and then forget about it for 6 months. Easily 5 bag from here.All imho
22/2/2021
12:46
dealit: Patience is needed, I feel March key for GDR share price going North IMHO based on past announcements from the Company.
17/2/2021
09:08
hazl: Interesting more detail from company available ....note at the end. ' Genedrive Share News (GDR) 4 Buy Sell Share Name Share Symbol Market Type Share ISIN Share Description Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 20.50 15.77% 150.50 150.00 151.00 163.50 139.50 144.50 1,100,592 08:46:31 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Pharmaceuticals & Biotechnology 1.1 -20.4 -55.0 - 85 Print Alert Genedrive PLC First US shipments of Genedrive(R) 96 SARS-CoV-2 Kit 17/02/2021 7:00am RNS Non-Regulatory TIDMGDR Genedrive PLC 17 February 2021 REACH genedrive plc ("genedrive" or the "Company") First shipments to US of Genedrive(R) 96 SARS-CoV-2 Kit 'genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces the first shipments to the United States of its Genedrive(R) 96 SARS-CoV-2 Kits. Following the Company's announcement on 28 January 2021 confirming genedrive's distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter"), genedrive can confirm that it has completed its commercial and technical training with the Beckman Coulter sales representatives and has now shipped its first 96 SARS-CoV-2 Kits to the USA. This shipment will allow Beckman Coulter to commence initial sales activities and prepare the market for wider commercial rollout. This shipment coincides with the formal launch of the Genedrive(R) 96 SARS-CoV-2 Kit by Beckman Coulter today.' To learn more about the partnership or to request a quote, Beckman Coulter customers can visit : https://www.beckman.com/reagents/genomic/viral-detection/genedrive-96-sars-cov-2
16/2/2021
16:26
sep800: GDR... Been consolidating over the last 2-3 trading days now. MM's stocking up as they hold the share price between 130p - 140p range. Flushing out weak sellers as they continue to accumulate as many shares as possible. Shares in issue very limited hence the huge movements in both directions. Anticipated news will see GDR push through 200 - 250p before pushing back up to 300p plus. Hence why the MM's need shares now. Even if we get just £1 per test, GDR will only need to produce 80M kits to equal its market Cap. But the world requires tens of millions if not Billions of these tests. A M/C of £300m plus is conservative. What would be a huge game changer here is a buy out by one a major pharmaceutical companies. These tests are going to be here for a few years there fore guarantee revenue will continue to push the share price north. ADYOR
Genedrive share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
GDR
Genedrive
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210512 03:06:51